Recurrent T cell receptor rearrangements in the cytotoxic T lymphocyte response in vivo against the P815 murine tumor

Journal of Experimental Medicine

Volumn 183, Issue 2, 1996, Pages 439-449

  Levraud, Jean Pierre ^a   Pannetier, Christophe ^a   Langlade Demoyen, Pierre ^a   Brichard, Vincent ^b   Kourilsky, Philippe ^a  

^a INSERM   (France)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GENE REARRANGEMENT; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOGENICITY; MALE; MASTOCYTOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR REJECTION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, NEOPLASM; BASE SEQUENCE; CLONE CELLS; FEMALE; GENE REARRANGEMENT, BETA-CHAIN T-CELL ANTIGEN RECEPTOR; GRAFT REJECTION; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MAST-CELL SARCOMA; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, INBRED DBA; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SARCOMA, EXPERIMENTAL; SEQUENCE ANALYSIS, DNA; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0030024684     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.183.2.439     Document Type: Article

References (36)

1. Davis, M.M., and P.J. Bjorkman. 1988. T-cell antigen receptor genes and T-cell recognition. Nature (Lond.). 334:395-402.
2. Casanova, J.-L., and J.L. Maryanski. 1993. Antigen-selected T cell receptor diversity and self-nonself homology. Immunol. Today. 14:391-394.
3. Cibotti, R., J.-P. Cabaniols, C. Pannetier, C. Debrbre, I. Vergnon, J.M. Kanellopoulos, and P. Kourilsky. 1994. Public and private Vβ T cell receptor repertoires against hen egg white lysozyme (HEL) in nontransgenic versus HEL transgenic mice. J. Exp. Med. 180:861-872.
4. Dunn, T.B., and M. Potter. 1957. A transplantable mast-cell neoplasm in the mouse. JNCI (Journal of the National Cancer Institute). 18:587-595.
5. Uyttenhove, C., J. Maryanski, and T. Boon. 1983. Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen-loss variants rather than immunosuppression. J. Exp. Med. 157:1040-1052.
6. Brichard, V.G., G. Warmer, A. Van Pel, G. Morlighem, S. Lucas, and T. Boon. 1995. Individual differences in the orientation of the cytolytic T cell response against mouse tumor P815. Eur. J. Immunol. 25:664-671.
7. Lethé, B., B. Van Den Eynde, A. Van Pel, G. Corradin, and T. Boon. 1992. Mouse tumor rejection antigens P815A and P815B: two epitopes carried by a single peptide. Eur. J. Immunol. 22:2283-2288
8. Van den Eynde, B., B, Lethé, A. Van Pel, E. De Plaen, and T. Boon. 1991. The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice. J. Exp. Med. 173:1373-1384.
9. Boon, T., J.-C. Cerottini, B. Van den Eynde, P. van der Bruggen, and A. Van Pel. 1994. Tumor antigens recognized by T lymphocytes. Annu. Rev. Immunol. 12:337-365.
10. Van Pel. A., E. De Plaen, and T. Boon. 1985. Selection of highly transfectable variant from mouse mastocytoma P815. Somatic Cell Mol. Genet. 11:467-475.
11. Ley, V., C. Roth, P. Langlade-Demoyen, E.-L. Larsson-Sciard, and P. Kourilsky. 1990. A novel approach to the induction of specific cytolytic T cells in vivo. Res. Immunol. 141: 855-863.
12. Hirsch, H.H., A.P.K. Nair, and C. Moroni. 1993. Suppressible and nonsuppressible autocrine mast cell tumors are distinguished by insertion of an endogenous retroviral element (IAP) into the interleukm 3 gene. J. Exp. Med. 178:403-411.
13. Ley, V., P. Langlade-Demoyen, P. Kourilsky, and E.-L. Larsson-Sciard. 1991. Interleukin 2-dependent activation of tumor-specific cytotoxic T lymphocytes in vivo. Eur. J. Immunol. 21:851-854.
14. Pannetier, C., M. Cochet, S. Darche, A. Casrouge, M. Zöller, and P. Kourdsky. 1993. The sizes of the CDR3 hypervariable regions of the murine T-cell receptor β chains vary as a function of the recombined germ-line segments. Proc Natl. Acad. Sci. USA. 90:4319-4323.
15. Chirgwin, J.M., A.E. Pizybyla, R.K. MacDonald, and W.J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 18:5294-5299.
16. Cochet, M., C. Pannetier, A. Regnault, S. Darche, C. Leclerc, and P. Kourilsky. 1992. Molecular detection and in vivo analysis of the specific T cell response to a protein antigen. Eur. J. Immunol. 22:2639-2647.
17. Casanova, J.-L., C. Pannetier, C. Jaulin, and P. Kourilsky. 1990. Optimal conditions for directly sequencing double-stranded PCR products with Sequenase. Nucleic Acids Res. 18:4028.
18. Pannetier, C., S. Delassus, S. Darche, C. Saucier, and P. Kourilsky. 1993. Quantitative titration of nucleic acids by enzymatic amplification reactions run to saturation. Nucleic Acids Res. 21:577-583.
19. Delassus, S., G.C. Coutinho, C. Saucier, S. Darche, and P. Kourilsky. 1994. Differential cytokine expression in maternal blood and placenta during murine gestation. J. Immunol. 152: 2411-2420.
20. Chothia, C., D. Ross Boswell, and A.M. Lesk. 1988. The outline structure of the T-cell αβ receptor. EMBO (Eur. Mol. Biol. Organ.) J. 7:3745-3755
21. Yoshino, I., T. Yano, Y. Yoshikai, M. Murata, K. Sugimachi, G. Kimura, and K Nomoto. 1991. Ohgoclonal T lymphocytes infiltrating human lung cancer tissues. Int. J. Cancer. 47:654-658.
22. Weidmann, E., T.L. Whiteside. R. Giorda, R.B. Herbemann, and M. Trucco. 1992. The T-cell receptor Vβ usage in tumor-infiltrating lymphocytes and blood of patients with hepatocellular carcinoma. Cancer Res. 52:5913-5920.
23. Weidmann, E., E.M. Eider, M. Trucco, M.T. Lotze, and T.L. Whiteside. 1993. Usage of T-cell receptor Vβ chain genes in fresh and cultured tumor-infiltrating lymphocytes from human melanoma. Int. J. Cancer. 54:383-390.
24. Puisteux, I., J. Even, C. Pannetier, F Jotereau, M. Favrot, and P. Kourilsky. 1994. Oligoclonality of tumor-infiltrating lymphocytes from human melanomas. J. Immunol. 153:2807-2818.
25. a and is recognized by cytotoxic T lymphocytes against mouse tumor P815. Eur. J. Immunol. 24: 2740-2745.
26. Takei, F., J.G. Levy, and D.G. Kilburn. 1976. In vitro induction of cytotoxicity against syngeneic mastocytoma and its suppression by spleen and thymus cells from tumor-bearing mice. J. Immunol. 116:288-293.
27. + effector T cells during progressive growth of the P815 mastocytoma. Immunology. 54:47-56.
28. Urban, J.L., V. Kumar, D.H. Kono, C. Gomez, S.J. Horvath, J. Clayton, J.G. Ando, E.E. Sercaz, and L. Hood. 1988. Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy. Cell. 54:577-592.
29. Van Der Bruggen, P., C. Traversari, P. Chomez, P. Lurquin, E. De Plaen, B. Van den Eynde, A. Knuth, and T. Boon. 1991. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science (Wash. DC). 254:1643-1647.
30. De Smet, C., C. Lurquin, P. Van der Bruggen, E. De Plaen, F. Brasseur, and T. Boon. 1994. Sequence and expression pattern of the human MAGE2 gene. Immunogenetics. 39:121-129.
31. Boël, P., C. Wildmann, M.L. Sensi, R. Brasseur, J.-C. Renauld, P. Coulie, T. Boon, and P. van Bruggen. 1995. BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity. 2: 161-175.
32. Brichard, V., A. Van Pel, T. Wölfel, E. De Plaen, B. Lethé, P. Coulie, and T. Boon. 1993. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 178:489-495.
33. Coulie, P.G., V. Brichard, A. Van Pel, T. Wölfel, J. Schneider, C. Traversari, S. Mattel, E. De Plaen, C. Lurquin, J.-P. Szikora, et al. 1994. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 180:35-42.
34. Bowness, P., P.A. Moss, S. Rowland-Jones, J.I. Bell, and A.J. McMichael. 1993. Conservation of T cell receptor usage by HLA-B27-restricted influenza-specific cytotoxic T lymphocytes suggests a general pattern for antigen-specific major histocompatibility complex class I-restricted responses. Eur. J. Immunol. 23:1417-1421.
35. Argaet, V.P., C.W. Schmidt, S.R. Burrows, S.L. Silins, M.G. Kurilla, D.L. Doolan, A. Suhrbier, D.J. Moss, E. Kieff, T.B. Sculley, and I.H. Misko. 1994. Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus. J. Exp. Med. 180:2335-2340.
36. Lehner, P.J., E.C.Y. Wang, P.A.H. Moss, S. Williams, K. Platt, S.M. Friedman, J.I. Bell, and L.K. Borysiewicz. 1995. Human HLA-A0201-restricted cytotoxic T lymphocyte recognition of influenza A is dominated by T cells bearing the Vβ17 gene segment. J. Exp. Med. 181:79-91.